Form EFFECT RedHill Biopharma Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 9, 2025 |
| Accession Number: | 0001178913-25-003257 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Strategy and Outlook Presentation 2026
- Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
- François Desné Appointed Arkema’s Senior Vice President High Performance Polymers and Fluorogases and Member of the Executive Committee
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
